NASDAQ
11.00USD
+11.00 (0.00%)
We have scored 5 news catalysts on Evoke Pharma, Inc. (EVOK) over the past 12 months. The biggest single-day move next to one of them came Nov 27, 2025, when EVOK closed +0.4%: “Entain, Evoke and Flutter warn of jobs cuts and illegal gambling due to Budget tax hike”. Coverage across the window leans mixed (average ticker sentiment +0.02). Most of the impact sits in sector consumer and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
18.9M
P/E
—
EPS
—
Beta
-0.14
52W range
1.94-11
Day range
11.00–11.00
Open
11.00
Prev close
11.00
Volume
47.1K
Avg volume
100.4K
Dividend
0.00
IPO
2013-09-25
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Evoke Pharma, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for EVOK: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead development candidate is Gimoti, a metoclopramide nasal spray, which has progressed through and completed its Phase 3 clinical trials. This medicine is being developed to mitigate symptoms associated with both acute and recurring diabetic gastroparesis, specifically in female patients. Evoke Pharma distributes its offerings to a broad base of healthcare professionals, encompassing digestive disease specialists, internists, general practitioners, and certain other medical providers. Established in 2007, the company's corporate offices are situated in Solana Beach, California.
